FR2244539B1 - - Google Patents

Info

Publication number
FR2244539B1
FR2244539B1 FR7325766A FR7325766A FR2244539B1 FR 2244539 B1 FR2244539 B1 FR 2244539B1 FR 7325766 A FR7325766 A FR 7325766A FR 7325766 A FR7325766 A FR 7325766A FR 2244539 B1 FR2244539 B1 FR 2244539B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7325766A
Other languages
French (fr)
Other versions
FR2244539A1 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsui Pharmaceuticals Inc
Original Assignee
Mitsui Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsui Pharmaceuticals Inc filed Critical Mitsui Pharmaceuticals Inc
Priority to FR7325766A priority Critical patent/FR2244539A1/fr
Publication of FR2244539A1 publication Critical patent/FR2244539A1/fr
Application granted granted Critical
Publication of FR2244539B1 publication Critical patent/FR2244539B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/35—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycobacteriaceae (F)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
FR7325766A 1973-07-13 1973-07-13 Tuberculin active proteins and peptides prepn - from tubercle bacillus Granted FR2244539A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR7325766A FR2244539A1 (en) 1973-07-13 1973-07-13 Tuberculin active proteins and peptides prepn - from tubercle bacillus

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7325766A FR2244539A1 (en) 1973-07-13 1973-07-13 Tuberculin active proteins and peptides prepn - from tubercle bacillus

Publications (2)

Publication Number Publication Date
FR2244539A1 FR2244539A1 (en) 1975-04-18
FR2244539B1 true FR2244539B1 (xx) 1976-12-31

Family

ID=9122550

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7325766A Granted FR2244539A1 (en) 1973-07-13 1973-07-13 Tuberculin active proteins and peptides prepn - from tubercle bacillus

Country Status (1)

Country Link
FR (1) FR2244539A1 (xx)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6458366B1 (en) 1995-09-01 2002-10-01 Corixa Corporation Compounds and methods for diagnosis of tuberculosis
US6290969B1 (en) 1995-09-01 2001-09-18 Corixa Corporation Compounds and methods for immunotherapy and diagnosis of tuberculosis
US6592877B1 (en) 1995-09-01 2003-07-15 Corixa Corporation Compounds and methods for immunotherapy and diagnosis of tuberculosis
EP1712629A3 (en) * 1995-09-01 2009-09-09 Corixa Corporation Compounds and methods for diagnosis of tuberculosis
SI0851927T1 (en) * 1995-09-01 2004-02-29 Corixa Corporation Compounds for immunotherapy and diagnosis of tuberculosis
IL129389A0 (en) * 1996-10-11 2000-02-17 Corixa Corp Compounds and methods for diagnsosis of tuberculosis
US8143386B2 (en) 1999-04-07 2012-03-27 Corixa Corporation Fusion proteins of mycobacterium tuberculosis antigens and their uses
EP1229931A4 (en) 1999-10-07 2003-05-28 Corixa Corp FUSION PROTEINS FROM MYCOBACTERIUM TUBERCULOSIS
AU2001241738A1 (en) 2000-02-25 2001-09-03 Corixa Corporation Compounds and methods for diagnosis and immunotherapy of tuberculosis
PT2133100E (pt) 2000-06-20 2012-01-11 Corixa Corp Antigénio mtb32a de mycobacterium tuberculosis com um local activo inactivado e suas proteínas de fusão
WO2003070187A2 (en) 2002-02-15 2003-08-28 Corixa Corporation Fusion proteins of mycobacterium tuberculosis

Also Published As

Publication number Publication date
FR2244539A1 (en) 1975-04-18

Similar Documents

Publication Publication Date Title
AR201758A1 (xx)
AU465372B2 (xx)
AR201235Q (xx)
AR201231Q (xx)
AU474593B2 (xx)
AU474511B2 (xx)
AU465453B2 (xx)
AU465434B2 (xx)
AU471343B2 (xx)
AU450229B2 (xx)
FR2244539B1 (xx)
AR201229Q (xx)
AU466283B2 (xx)
AU472848B2 (xx)
AR199451A1 (xx)
AU477823B2 (xx)
JPS5328966B2 (xx)
AU447540B2 (xx)
AU476873B1 (xx)
AR196382A1 (xx)
AR201432A1 (xx)
AR193950A1 (xx)
AR210729A1 (xx)
AR195311A1 (xx)
AU471461B2 (xx)

Legal Events

Date Code Title Description
ST Notification of lapse